ARTICLE | Clinical News
NP137: Ph I started
March 29, 2017 12:55 AM UTC
Netris began an open-label, 2-part, French Phase I trial to evaluate IV NP137 given every other week in about 44 patients. The dose-escalation part 1 will evaluate 1, 2, 4, 6, 9, 14 and 20 mg/kg doses...
BCIQ Company Profiles
BCIQ Target Profiles